1. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2006; 8: 746–837.
2. Maron BJ. Hypertrophic cardiomiopathy. In E Braunwald, 
P Libby, R Bonow et al. Heart disease. Saunders Company 
2008: 1763–74.
3. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnotmalities. Circulation 2008; 117: e350–e408.
4. Mc Kenna WJ, Oakley CM, Krikler DM et al. Improved survival with amiodarone in patients with hypertrophic cardiomiopathy and ventricular tachycardia. Br Heart J 1985; 53: 412–6.
5. Fanapazir L, Leon MB, Bonow RO et al. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomiopathy. Am J Cardiol 1991; 67: 169–74.
6. Moric-Janiszewska E, Markiewicz-Loskot G. Review on the genetics of arrhythmogenic right ventricular dysplasia. Europace 2007; 9: 259–66.
7. Rashba EJ, Link MS, Estes NA. Long Q–T syndrome, Brugada syndrome, right ventricular cardiomiopathy, hypertrophic cardiomiopathy and commotion cordis. In LI Ganz, E Braunwald  (eds). Management of cardiac arrhythmias. Humana Press 2004; 379–418.
8. Tandri H, Saranathan M, Rodriguez ER et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomiopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005; 45: 98–103.
9. Chiang CE Congential and acquired long Q–T syndrome. Cardiol in Rev 2004; 12: 222–34.
10. Moss AJ, Schwartz PJ, Crampton RS et al. The long Q–T syndrome: a prospective international study. Circulation 1985; 71: 17–21.
11. Priori SG, Napolitano C, Schwartz PJ. Genetics of cardiac arrhythmias. In E Braunwald, P Libby, R Bonow et al. Heart disease. Saunders Company 2008; 101–9.
12. Olgin JS, Zipes DP. Specific arrhythmias: diagnosis and treatment. In E Braunwald, P Libby, R Bonow et al. Heart disease. Saunders Company 2008; 863–923.
13. Sudden death syndromes. In Zimetbaum PJ, Josephson ME. Practical clinical electrophysiology. Lippincott Williams 2009; 193–218.
14. Priori SG, Schwartz PJ, Napolitano C et al. Risk strafication in the long-Q–T syndrome. N Engl J Med 2003; 348: 1866–74.
15. Priori SG, Napolitano C, Schwartz PJ et al. Association of long Q–T syndrome loci and cardiac events among patients treated with beta-blokers. JAMA 2004; 292: 1341–5.
16. Gussak I, Brugada P, Brugada J et al. Idiopathic short Q–T interval: a new clinical syndrome? Cardiology 2000; 94: 99–102.
17. Schimpf R, Wolpert C, Gaita F et al. Short Q–T syndrome. Cardiovasc Res 2005; 67: 357–61.
18. Gaita F, Giustetto C, Bianchi F. Short Q–T syndrome: pharmacological treatment. JACC 2004; 43: 1494–9.
19. Paul M, Gerss J, Schulze-Bahr E et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J 2007; 28: 2126–33.
20. Marquez MF, Salica G, Hermosillo AG et al. Drug therapy in Brugada syndrome. Curr Drug Targets Cardiovasc Haematol Disord 2005; 5: 409–17.
21. Coumel P, Fidelle J, Lucet V et al. Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children. Br Heart J 1978; 40: 28–37.
22. Anderson KP, Brode S, Gottipaty V et al. Pharmacologic therapy of ventricular tachyarrhythmias. In LI Ganz, E Braunwald (eds). Management of cardiac arrhythmias. Humana Press 2004; 331–57.
23. Ventricular tachycardia. In PJ Zimetbaum, ME Josephson. Practical clinical electrophysiology. Lippincott Williams 2009; 137–61.
24. Ventura R, Steven D, Klemm HU et al. Decennial follow-up patients with recurrent tachycardia originating from the right ventricular outflow tract. Eur Heart J 2007; 28: 2338–45.
25. Bennett DH. Cardiac arrhythmias. Hodder Arnold 2006.

Ю.А.Бунин 

ГБОУ ДПО РМАПО Минздрава РФ, Москва